{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T10:04:04Z","timestamp":1776161044595,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-70890-6","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T09:02:39Z","timestamp":1776157359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unexpected detection of Mycobacterium tuberculosis DNA in US-born patients in putative association with clinical syndromes"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6323-286X","authenticated-orcid":false,"given":"Edward C.","family":"Jones-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5878-0896","authenticated-orcid":false,"given":"Nancy S.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverley","family":"Orr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura F.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solange","family":"Vinhas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moses","family":"Mpeirwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Orikiriza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliet","family":"Mwanga-Amumpaire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moises","family":"Palaci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reynaldo","family":"Dietze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"II","given":"Yap","family":"Boum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Madico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"70890_CR1","unstructured":"World Health Organization. Global tuberculosis report 2023. License: CC BY-NC-SA 3.0 IGO (World Health Organization, Geneva, 2023)."},{"key":"70890_CR2","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1164\/rccm.201806-1053PP","volume":"199","author":"S Keshavjee","year":"2019","unstructured":"Keshavjee, S. et al. Moving toward tuberculosis elimination. Critical issues for research in diagnostics and therapeutics for tuberculosis infection. Am. J. Respir. Crit. Care Med. 199, 564\u2013571 (2019).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"70890_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30024-8","author":"MJA Reid","year":"2019","unstructured":"Reid, M. J. A. et al. Building a tuberculosis-free world: the Lancet Commission on tuberculosis. Lancet https:\/\/doi.org\/10.1016\/S0140-6736(19)30024-8 (2019).","journal-title":"Lancet"},{"key":"70890_CR4","doi-asserted-by":"crossref","unstructured":"Schildknecht, K. R., Pratt, R. H., Feng, P. I., Price, S. F. & Self, J. L. Tuberculosis - United States, 2022. MMWR Morb. Mortal. Wkly. Rep. 72, 297\u2013303 (2023).","DOI":"10.15585\/mmwr.mm7212a1"},{"key":"70890_CR5","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1056\/NEJMp1707387","volume":"377","author":"R Bayer","year":"2017","unstructured":"Bayer, R. & Castro, K. G. Tuberculosis elimination in the United States\u2014the need for renewed action. N. Engl. J. Med. 377, 1109\u20131111 (2017).","journal-title":"N. Engl. J. Med."},{"key":"70890_CR6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.tube.2015.04.003","volume":"95","author":"P Salgame","year":"2015","unstructured":"Salgame, P., Geadas, C., Collins, L., Jones-Lopez, E. & Ellner, J. J. Latent tuberculosis infection\u2014revisiting and revising concepts. Tuberculosis 95, 373\u2013384 (2015).","journal-title":"Tuberculosis"},{"key":"70890_CR7","doi-asserted-by":"publisher","first-page":"e1006687","DOI":"10.1371\/journal.ppat.1006687","volume":"13","author":"TJ Scriba","year":"2017","unstructured":"Scriba, T. J. et al. Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease. PLoS Pathog. 13, e1006687 (2017).","journal-title":"PLoS Pathog."},{"key":"70890_CR8","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1164\/rccm.201607-1431ED","volume":"194","author":"V Dartois","year":"2016","unstructured":"Dartois, V., Saito, K., Warrier, T. & Nathan, C. New evidence for the complexity of the population structure of Mycobacterium tuberculosis increases the diagnostic and biologic challenges. Am. J. Respir. Crit. Care Med. 194, 1448\u20131451 (2016).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"70890_CR9","doi-asserted-by":"publisher","unstructured":"Drain, P. K. et al. Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection. Clin. Microbiol. Rev. 31, https:\/\/doi.org\/10.1128\/CMR.00021-18 (2018).","DOI":"10.1128\/CMR.00021-18"},{"key":"70890_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07635-7","volume":"9","author":"J Weiner","year":"2018","unstructured":"Weiner, J. et al. Metabolite changes in blood predict the onset of tuberculosis. Nat. Commun. 9, 5208 (2018).","journal-title":"Nat. Commun."},{"key":"70890_CR11","first-page":"20130437","volume":"369","author":"H Esmail","year":"2014","unstructured":"Esmail, H., Barry, C. E. III, Young, D. B. & Wilkinson, R. J. The ongoing challenge of latent tuberculosis. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci. 369, 20130437 (2014).","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"70890_CR12","doi-asserted-by":"publisher","first-page":"S1179","DOI":"10.1093\/infdis\/jir451","volume":"204","author":"JM Achkar","year":"2011","unstructured":"Achkar, J. M. & Jenny-Avital, E. R. Incipient and subclinical tuberculosis: defining early disease states in the context of host immune response. J. Infect. Dis. 204, S1179\u2013S1186 (2011).","journal-title":"J. Infect. Dis."},{"key":"70890_CR13","doi-asserted-by":"publisher","first-page":"e187617","DOI":"10.1001\/jamanetworkopen.2018.7617","volume":"2","author":"MH Nguyen","year":"2019","unstructured":"Nguyen, M. H. et al. Factors associated with sputum culture-negative vs culture-positive diagnosis of pulmonary tuberculosis. JAMA Netw. Open 2, e187617 (2019).","journal-title":"JAMA Netw. Open"},{"key":"70890_CR14","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1164\/rccm.201207-1217OC","volume":"187","author":"DW Dowdy","year":"2013","unstructured":"Dowdy, D. W., Basu, S. & Andrews, J. R. Is passive diagnosis enough? The impact of subclinical disease on diagnostic strategies for tuberculosis. Am. J. Respir. Crit. Care Med. 187, 543\u2013551 (2013).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"70890_CR15","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/s42003-024-06912-0","volume":"7","author":"B Gap-Gaupool","year":"2024","unstructured":"Gap-Gaupool, B. et al. Nitric oxide induces the distinct invisibility phenotype of Mycobacterium tuberculosis. Commun. Biol. 7, 1206 (2024).","journal-title":"Commun. Biol."},{"key":"70890_CR16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S2213-2600(19)30038-4","volume":"7","author":"R Houben","year":"2019","unstructured":"Houben, R. et al. Spotting the old foe-revisiting the case definition for TB. Lancet Respir. Med. 7, 199\u2013201 (2019).","journal-title":"Lancet Respir. Med."},{"key":"70890_CR17","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S2213-2600(24)00028-6","volume":"12","author":"AK Coussens","year":"2024","unstructured":"Coussens, A. K. et al. Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise. Lancet Respir. Med. 12, 484\u2013498 (2024).","journal-title":"Lancet Respir. Med."},{"key":"70890_CR18","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/S0140-6736(25)00555-0","volume":"405","author":"K Dheda","year":"2025","unstructured":"Dheda, K., Perumal, T. & Fox, G. J. Asymptomatic tuberculosis: undetected and underestimated, but not unimportant. Lancet 405, 1797\u20131800 (2025).","journal-title":"Lancet"},{"key":"70890_CR19","doi-asserted-by":"publisher","first-page":"e0158371","DOI":"10.1371\/journal.pone.0158371","volume":"11","author":"G Madico","year":"2016","unstructured":"Madico, G. et al. Detection and quantification of Mycobacterium tuberculosis in the sputum of culture-negative HIV-infected pulmonary tuberculosis suspects: a proof-of-concept study. PLoS ONE 11, e0158371 (2016).","journal-title":"PLoS ONE"},{"key":"70890_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tube.2019.03.007","volume":"116","author":"G Madico","year":"2019","unstructured":"Madico, G. et al. Further evidence of Mycobacterium tuberculosis in the sputum of culture-negative pulmonary tuberculosis suspects using an ultrasensitive molecular assay. Tuberculosis 116, 1\u20137 (2019).","journal-title":"Tuberculosis"},{"key":"70890_CR21","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1016\/S1473-3099(18)30111-7","volume":"18","author":"G Walzl","year":"2018","unstructured":"Walzl, G. et al. Tuberculosis: advances and challenges in development of new diagnostics and biomarkers. Lancet Infect. Dis. 18, e199\u2013e210 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"70890_CR22","doi-asserted-by":"publisher","first-page":"e1002786","DOI":"10.1371\/journal.pmed.1002786","volume":"16","author":"H Warsinske","year":"2019","unstructured":"Warsinske, H., Vashisht, R. & Khatri, P. Host-response-based gene signatures for tuberculosis diagnosis: a systematic comparison of 16 signatures. PLoS Med. 16, e1002786 (2019).","journal-title":"PLoS Med."},{"key":"70890_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S2213-2600(20)30050-3","volume":"8","author":"M Bonnet","year":"2020","unstructured":"Bonnet, M. Xpert MTB\/RIF Ultra: what is the real impact?. Lancet Respir. Med. 8, 325\u2013326 (2020).","journal-title":"Lancet Respir. Med."},{"key":"70890_CR24","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/cid\/ciy584","volume":"67","author":"JM Miller","year":"2018","unstructured":"Miller, J. M. et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin. Infect. Dis. 67, 813\u2013816 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"70890_CR25","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1093\/cid\/cit027","volume":"56","author":"NS Hochberg","year":"2013","unstructured":"Hochberg, N. S. & Horsburgh, C. R. Jr Prevention of tuberculosis in older adults in the United States: obstacles and opportunities. Clin. Infect. Dis. Publ. Infect. Dis. Soc. Am. 56, 1240\u20131247 (2013).","journal-title":"Clin. Infect. Dis. Publ. Infect. Dis. Soc. Am."},{"key":"70890_CR26","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1164\/rccm.201603-0439ED","volume":"194","author":"CC Whalen","year":"2016","unstructured":"Whalen, C. C. The replacement principle of tuberculosis. Why prevention matters. Am. J. Respir. Crit. Care Med. 194, 400\u2013401 (2016).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"70890_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37860-5","volume":"9","author":"L Gil-Santana","year":"2019","unstructured":"Gil-Santana, L. et al. Tuberculosis-associated anemia is linked to a distinct inflammatory profile that persists after initiation of antitubercular therapy. Sci. Rep. 9, 1381 (2019).","journal-title":"Sci. Rep."},{"key":"70890_CR28","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1056\/NEJM200006223422502","volume":"342","author":"EP Vichinsky","year":"2000","unstructured":"Vichinsky, E. P. et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N. Engl. J. Med. 342, 1855\u20131865 (2000).","journal-title":"N. Engl. J. Med."},{"key":"70890_CR29","doi-asserted-by":"publisher","first-page":"e1458","DOI":"10.1016\/S2214-109X(19)30328-6","volume":"7","author":"S Uyoga","year":"2019","unstructured":"Uyoga, S. et al. The epidemiology of sickle cell disease in children recruited in infancy in Kilifi, Kenya: a prospective cohort study. Lancet Glob. Health 7, e1458\u2013e1466 (2019).","journal-title":"Lancet Glob. Health"},{"key":"70890_CR30","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3201\/eid2403.171633","volume":"24","author":"DT Nguyen","year":"2018","unstructured":"Nguyen, D. T., Teeter, L. D., Graves, J. & Graviss, E. A. Characteristics associated with negative interferon-gamma release assay results in culture-confirmed tuberculosis patients, Texas, USA, 2013-2015. Emerg. Infect. Dis. 24, 534\u2013540 (2018).","journal-title":"Emerg. Infect. Dis."},{"key":"70890_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-58459-9","volume":"10","author":"M Yamasue","year":"2020","unstructured":"Yamasue, M. et al. Factors associated with false negative interferon-gamma release assay results in patients with tuberculosis: a systematic review with meta-analysis. Sci. Rep. 10, 1607 (2020).","journal-title":"Sci. Rep."},{"key":"70890_CR32","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/cid\/ciad595","volume":"78","author":"J Sung","year":"2024","unstructured":"Sung, J. et al. Evidence for tuberculosis in individuals with Xpert Ultra \u201cTrace\u201d sputum during screening of high-burden communities. Clin. Infect. Dis. 78, 723\u2013729 (2024).","journal-title":"Clin. Infect. Dis."},{"key":"70890_CR33","doi-asserted-by":"publisher","DOI":"10.1101\/2025.03.20.25324205","author":"J Sung","year":"2025","unstructured":"Sung, J. et al. The long-term risk of tuberculosis among individuals with Xpert Ultra \u201ctrace\u201d screening results: a longitudinal follow-up study. medRxiv https:\/\/doi.org\/10.1101\/2025.03.20.25324205 (2025).","journal-title":"medRxiv"},{"key":"70890_CR34","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMc1513236","volume":"375","author":"AH Diacon","year":"2016","unstructured":"Diacon, A. H. et al. Beta-Lactams against Tuberculosis\u2013New Trick for an Old Dog?. N. Engl. J. Med. 375, 393\u2013394 (2016).","journal-title":"N. Engl. J. Med."},{"key":"70890_CR35","doi-asserted-by":"publisher","first-page":"213sr216","DOI":"10.1126\/scitranslmed.3007402","volume":"5","author":"RL Modlin","year":"2013","unstructured":"Modlin, R. L. & Bloom, B. R. TB or not TB: that is no longer the question. Sci. Transl. Med. 5, 213sr216 (2013).","journal-title":"Sci. Transl. Med."},{"key":"70890_CR36","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1093\/cid\/cix479","volume":"65","author":"SW Pan","year":"2017","unstructured":"Pan, S. W. et al. Microbiological persistence in patients with Mycobacterium avium complex lung disease: the predictors and the impact on radiographic progression. Clin. Infect. Dis. 65, 927\u2013934 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"70890_CR37","doi-asserted-by":"publisher","first-page":"e1007613","DOI":"10.1371\/journal.ppat.1007613","volume":"15","author":"S Verma","year":"2019","unstructured":"Verma, S. et al. Transmission phenotype of Mycobacterium tuberculosis strains is mechanistically linked to induction of distinct pulmonary pathology. PLoS Pathog. 15, e1007613 (2019).","journal-title":"PLoS Pathog."},{"key":"70890_CR38","unstructured":"Boston Public Health Commission, Research and Evaluation Office. Health of Boston 2012\u20132013: A Neighborhood Focus. (Boston, MA, 2013)."},{"key":"70890_CR39","unstructured":"Clinical and Laboratory Standards Institute. Establishing Molecular Testing in Clinical Laboratory Environments; Proposed Guideline. CLSI document MM19-P. (Clinical and Laboratory Standards Institute, Wayne, PA, 2011)."},{"key":"70890_CR40","doi-asserted-by":"publisher","first-page":"40","DOI":"10.7326\/0003-4819-138-1-200301070-00010","volume":"138","author":"PM Bossuyt","year":"2003","unstructured":"Bossuyt, P. M. et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Ann. Intern. Med. 138, 40\u201344 (2003).","journal-title":"Ann. Intern. Med."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70890-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70890-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70890-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T09:02:43Z","timestamp":1776157363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70890-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70890"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-70890-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Jones-L\u00f3pez and Dr. Madico are co-inventors of TOP TB assay\u2019s primers and probes. The invention is owned by Boston Medical Center\/Boston University Medical School, which has obtained an international patent application (US Patent and Trademark Office No. 10,190,176 B2). The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2709"}}